Experienced in Cholangiocarcinoma (Bile Duct Cancer)

Kentaro Yamazaki

Shizuoka, JP 
Experienced in Cholangiocarcinoma (Bile Duct Cancer)
Shizuoka, JP 
OverviewLocationsClinical Research

Overview

Kentaro Yamazaki practices in Shizuoka, Japan. Mr. Yamazaki is rated as an Experienced expert by MediFind in the treatment of Cholangiocarcinoma (Bile Duct Cancer). His top areas of expertise are Colorectal Cancer, Agranulocytosis, Stomach Cancer, Hepato-Pancreato-Biliary Surgery, and Endoscopy.

His clinical research consists of co-authoring 224 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Cholangiocarcinoma (Bile Duct Cancer).

Gender
Male

Locations

Shizuoka, Japan
Other Locations
Tokyo, Japan
Department Of Head And Neck Medical Oncology, 1007 Shimonagakubo, Nagaizumi, Sunto Gun, Shimonagakubo, 4118777, Japan
Fuchu, 1838538, Japan
Wako, 3510198, Japan
Shimo, 4118777, Japan
Gifu-shi, Japan
Fukuoka, Japan
Cho, Japan
Ichihara, Japan
Kyoto, Japan
Shizouka, Japan
Tsukuba, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
A Global Multicenter Randomized Placebo-Controlled Phase 3 Trial To Compare The Efficacy And Safety Of Fruquintinib Plus Best Supportive Care To Placebo Plus Best Supportive Care In Patients With Refractory Metastatic Colorectal Cancer
Enrollment Status: Completed
Publish Date: April 04, 2025
Intervention Type: Drug
Study Drug: Fruquintinib
Study Phase: Phase 3

224 Total Publications

Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study.
Chronological survival improvement over time with oxaliplatin-based chemotherapy plus targeted agents in metastatic colorectal cancer: An ARCAD database study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Yamazaki's expertise for a condition
ConditionClose
View All 24 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile